Overview

Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy

Status:
Completed

Trial end date:
2021-08-30

Target enrollment:

Participant gender:

Summary

In this study, investigators designed a double-blind randomized trial to compare the efficacy and safety between sodium valproate, amisulpride and MECT combination therapy in clozapine-treated refractory schizophrenia (CTRS).

Phase:

Phase 4

Details

Lead Sponsor:

Shanghai Mental Health Center

Treatments:

Amisulpride
Clozapine
Valproic Acid